ARTICLE | Company News
Affymax N.V. deal
March 21, 1994 8:00 AM UTC
AFMXF (The Netherlands) said Ciba-Geigy Ltd. has exercised its option to extend the companies' 1991 research collaboration for one year.
AFMXF is using its drug discovery technologies to identify drug candidates that interact with specific molecular targets, which have not been disclosed. Ciba will be responsible for clinical development and marketing. ...